Spectris (SXS) Receives “Outperform” Rating from BNP Paribas

Spectris (LON:SXS)‘s stock had its “outperform” rating reissued by equities researchers at BNP Paribas in a research report issued on Thursday.

Other equities research analysts also recently issued research reports about the company. Liberum Capital restated a “buy” rating and set a GBX 2,880 ($40.43) price objective on shares of Spectris in a report on Friday, January 26th. Shore Capital restated a “buy” rating on shares of Spectris in a report on Friday, January 26th. Goldman Sachs initiated coverage on Spectris in a research report on Wednesday, December 13th. They set a “buy” rating and a GBX 2,900 ($40.71) target price on the stock. Jefferies Group reaffirmed a “buy” rating and set a GBX 3,175 ($44.57) target price on shares of Spectris in a research report on Thursday, February 22nd. Finally, Deutsche Bank lifted their target price on Spectris from GBX 2,860 ($40.15) to GBX 2,960 ($41.55) and gave the company a “buy” rating in a research report on Monday, February 26th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of GBX 2,809.17 ($39.43).

How to Become a New Pot Stock Millionaire

LON SXS opened at GBX 2,649 ($37.18) on Thursday. Spectris has a 52 week low of GBX 2,225 ($31.23) and a 52 week high of GBX 2,869 ($40.27).

Spectris (LON:SXS) last released its quarterly earnings data on Monday, February 19th. The company reported GBX 145.10 ($2.04) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of GBX 133.40 ($1.87) by GBX 11.70 ($0.16). The firm had revenue of GBX 152.56 billion during the quarter. Spectris had a return on equity of 37.36% and a net margin of 25.86%.

In related news, insider John O’Higgins sold 2,837 shares of Spectris stock in a transaction that occurred on Wednesday, March 14th. The stock was sold at an average price of GBX 2,701 ($37.91), for a total transaction of £76,627.37 ($107,562.28).

COPYRIGHT VIOLATION NOTICE: “Spectris (SXS) Receives “Outperform” Rating from BNP Paribas” was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3337204/spectris-sxs-receives-outperform-rating-from-bnp-paribas.html.

About Spectris

Spectris plc manufactures and sells measuring instruments and controls worldwide. It operates through four segments: Materials Analysis, Test and Measurement, In-line Instrumentation, and Industrial Controls. The Materials Analysis segment provides products and services, which enable customers to determine structure, composition, quantity, and quality of particles and materials during their research and development processes, when assessing materials before production, or during the manufacturing process.

Analyst Recommendations for Spectris (LON:SXS)

Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Comparing ConvergeOne  & AgroFresh Solutions
Comparing ConvergeOne & AgroFresh Solutions
Analysts Set $59.00 Target Price for pdvWireless
Analysts Set $59.00 Target Price for pdvWireless
$559.12 Million in Sales Expected for Ferroglobe  This Quarter
$559.12 Million in Sales Expected for Ferroglobe This Quarter
Financial Contrast: NXT-ID  versus Allegion
Financial Contrast: NXT-ID versus Allegion
Head-To-Head Contrast: ReWalk Robotics  versus Invacare
Head-To-Head Contrast: ReWalk Robotics versus Invacare
Ethereum Cash Trading 178.8% Higher  Over Last Week
Ethereum Cash Trading 178.8% Higher Over Last Week


© 2006-2018 Ticker Report. Google+.